The Phase 1 clinical trial is expected to enroll about 60 participants to test how safe and well tolerated multiple doses of ...

NRG Therapeutics will use a new grant to advance preclinical studies of its class of oral small molecules as a potential ...

AcuraStem has received $4 million in funding from the California Institute for Regenerative Medicine (CIRM) to advance the ...

A strategy that simultaneously targets motor neurons, astrocytes, and microglia in ALS was found to extend survival in a ...

Measuring the levels of a novel protein biomarker called CXCL12 in the spinal fluid may improve the diagnosis of ALS, per a ...

The FDA has granted orphan drug status to Actimed Therapeutics' S-oxprenolol, a treatment candidate that aims to ease muscle ...

Living with her late husband's ALS taught columnist Juliet Taylor valuable lessons about what strength and weakness really ...

Columnist Kristin Neva reflects on her last state park outing with her husband, which seems a lifetime ago to her now.

Columnist Dagmar Munn, who worked in the fitness profession, knows that movement matters — so she plans a recess break for every hour.

A home care model tested in Germany was found feasible and enabled ALS patients to avoid the hospital and receive end-of-life ...

With a husband who has ALS, columnist Kristin Neva has to arrange for his care when she's making a commitment to be away from home.

Monepantel continues to slow ALS disease progression and extend survival when taken daily for up to nearly two years, interim data show.